Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in generic drugs

Strides Pharma Recalls BP Treatment Medicine In US

As per the latest enforcement report by the US Food and Drug Administration (USFDA), the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure lowering drug in the US market

Read More

Sun Pharma Recalls More Than 10,000 Bottles Of Generic Anti-depression Drug In US

According to the latest enforcement report of the US Food and Drug Administration (USFDA), the US arm of the domestic pharma major is recalling 10,548 bottles of bupropion hydrochloride extended-release tablets in the American market.

Read More

Choosing The Right Genomics Lab: Taking A Step Towards Genetic Testing

The most important aspect before selecting a laboratory is to check for its accreditationby institutions such as the College of American Pathologists (CAP)

Read More

Make In India: Pharmacy Sector

India's cost of production is significantly lower than that of the US and almost half of that of Europe which gives it a competitive edge to India

Read More

Foreign Firms Reluctant To Launch New Drugs In India, Says GIPC

The executive director of international intellectual property at GIPC is in India to talk about the simmering discontent over IPR infrastructure

Read More

Lupin To Buy 21 Branded Drugs From Japan's Shionogi

The portfolio will be transferred to Lupin on Dec. 31, subject to regulatory approvals and certain closing conditions, the companies said

Read More

Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug

The product is a generic version of Santarus Inc’s Zegerid powder for oral suspension, Ajanta Pharma says

Read More

Govt To Revise Drugs Law, Draft New Rules For Medical Devices

Ministers decided the current law cannot effectively regulate areas such as biological drugs, stem cells and regenerative medicines, medical devices, and clinical trials

Read More

Sun Pharma Gets US Subpoena Over Generic Drugs Pricing

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors

Read More

Ajanta Pharma Gets USFDA Approval Of Zolmitriptan Tablets

USFDA has granted Ajanta Pharma 9 ANDA final approvals and two tentative approvals. Additional 15 ANDAs are under review with the American regulator

Read More

Playing Cat And Mouse

This situation is unique to India, where sales growth of companies is closely connected to brand launches

Read More

Pharma Crusader Takes Drug Regulators To Court

Dinesh Thakur made his name, and almost $48 million as a whistleblower award from the United States, when US regulators fined Ranbaxy $500 million for violating federal drug safety laws

Read More

India Drug Monitoring Plan Struggles To Grow Fast Enough

There are problems ranging from a shortage of personnel, computers and funds to raise awareness among staff to a lack of cooperation from doctors who say they are too busy

Read More

Sun Hopes Cut-Price Generic Gleevec Will Win Third Of US Market

Sun North American CEO Kal Sundaram said initial shipments of the generic, made at the company's US facilities, should be on pharmacy shelves within two or three days

Read More

Sun Pharma Slumps After US Issues Warning On Standards Violations

The warning comes barely a month after rival Dr Reddy's Laboratories Ltd was reprimanded by the US Food and Drug Administration for issues including record-keeping at three of its plants

Read More